Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001610618-22-000036
Filing Date
2022-04-29
Accepted
2022-04-29 16:33:38
Documents
4
Period of Report
2022-06-22

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT cdtxdef14a2022.htm DEF 14A 515879
2 cdtx_proxycardxpg1.jpg GRAPHIC 2584251
3 cdtx_proxycardxpg2.jpg GRAPHIC 1334388
4 cdtxlogoa13a.jpg GRAPHIC 46741
  Complete submission text file 0001610618-22-000036.txt   5964731
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36912 | Film No.: 22876263
SIC: 2836 Biological Products, (No Diagnostic Substances)